Angiogenesis Inhibition: 180 (Recent Results in Cancer Research, 180) - Softcover
Book 10 of 157: Recent Results in Cancer Research
Synopsis
Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
"synopsis" may belong to another edition of this title.
From the Back Cover
Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies.
This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials on therapeutic compounds are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in research and treatment in this exciting field.
"About this title" may belong to another edition of this title.
Other Popular Editions of the Same Title
Search results for Angiogenesis Inhibition: 180 (Recent Results in Cancer...
Stock Image
Angiogenesis Inhibition.
Published by
Berlin/ Heidelberg, Springer Berlin., 2012
ISBN 10: 3642261434
ISBN 13: 9783642261435
Used
Softcover
Seller: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germany
Seller rating 4 out of 5 stars
2010. 16 x 24 cm. XIV, 231 S. XIV, 231 p. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. (Recent Results in Cancer Research). Sprache: Englisch. Seller Inventory # 71ZB
Stock Image
Angiogenesis Inhibition (Recent Results in Cancer Research, Band 180) [Paperback] Liersch, Rüdiger Berdel, Wolfgang E. and Kessler, Torsten
Seller: SpringBooks, Berlin, Germany
Seller rating 4 out of 5 stars
Softcover. Condition: As New. Like new. Immediately dispatched from Germany. Seller Inventory # CEN-2403C-CENKISTE7-07-0500k
Stock Image
Angiogenesis Inhibition (eng)
Print on DemandSeller: Brook Bookstore On Demand, Napoli, NA, Italy
Seller rating 3 out of 5 stars
Condition: new. Questo è un articolo print on demand. Seller Inventory # 2cf23489bcf294dca6b65b4c803014f3
Buy New
£ 83.86
£ 4.75 shipping
Ships from Italy to U.S.A.
Ships from Italy to U.S.A.
Quantity: Over 20 available
Stock Image
Angiogenesis Inhibition (Recent Results in Cancer Research, 180)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
Condition: New. In. Seller Inventory # ria9783642261435_new
Buy New
£ 107.12
£ 11.98 shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: Over 20 available
Seller Image
Angiogenesis Inhibition
Published by
Springer Berlin Heidelberg Mai 2012, 2012
ISBN 10: 3642261434
ISBN 13: 9783642261435
New
Taschenbuch
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field. 248 pp. Englisch. Seller Inventory # 9783642261435
Seller Image
Angiogenesis Inhibition
Published by
Springer Berlin Heidelberg, 2012
ISBN 10: 3642261434
ISBN 13: 9783642261435
New
Softcover
Seller: moluna, Greven, Germany
Seller rating 5 out of 5 stars
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A general overview of the latest developments in angiogenesis inhibition in cancerConsiders all aspects from the bench to the bedside, with detailed attention both to basic research and to its translation into clinical practicePresents the . Seller Inventory # 5054217
Buy New
£ 87.68
£ 42.32 shipping
Ships from Germany to U.S.A.
Ships from Germany to U.S.A.
Quantity: Over 20 available
Stock Image
Angiogenesis Inhibition (Recent Results in Cancer Research)
Seller: Revaluation Books, Exeter, United Kingdom
Seller rating 5 out of 5 stars
Paperback. Condition: Brand New. 2010 edition. 248 pages. 9.20x6.10x0.56 inches. In Stock. Seller Inventory # x-3642261434
Buy New
£ 138.49
£ 10 shipping
Ships from United Kingdom to U.S.A.
Ships from United Kingdom to U.S.A.
Quantity: 2 available
Seller Image
Angiogenesis Inhibition
Seller: preigu, Osnabrück, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. Angiogenesis Inhibition | Rüdiger Liersch (u. a.) | Taschenbuch | xiv | Englisch | 2012 | Springer | EAN 9783642261435 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. Seller Inventory # 106478593
Seller Image
Angiogenesis Inhibition
Published by
Springer, J.B. Metzler Mai 2012, 2012
ISBN 10: 3642261434
ISBN 13: 9783642261435
New
Taschenbuch
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 248 pp. Englisch. Seller Inventory # 9783642261435
Seller Image
Angiogenesis Inhibition
Published by
Springer Berlin Heidelberg, 2012
ISBN 10: 3642261434
ISBN 13: 9783642261435
New
Taschenbuch
Seller: AHA-BUCH GmbH, Einbeck, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field. Seller Inventory # 9783642261435